Immunotherapy in glioblastoma treatment: Current state and future prospects

doi:10.5306/wjco.v14.i4.138

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5490)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

270

WORD

HTML

3729

Figures (1-4)

216

Tables (1-1)

249

Sum=4499

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

165

Download

329

Sum=494

Publishing Process of This Article

Item

Count

Browse

160

Download

337

Sum=497

Apr 24, 2023 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (37)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Apr 24, 2023; 14(4): 138-159
Published online Apr 24, 2023. doi: 10.5306/wjco.v14.i4.138

Full Size Figure Download Figure

Figure 2 Simplified scheme of glioblastomas-induced immunosuppressive microenvironment. MDSCs: myeloid-derived suppressor cells; NK: Natural killer. The Figure was partly generated using Servier Medical Art, provided by Servier, licensed under a Creative Commons Attribution 3.0 unported license.

Citation: Rocha Pinheiro SL, Lemos FFB, Marques HS, Silva Luz M, de Oliveira Silva LG, Faria Souza Mendes dos Santos C, da Costa Evangelista K, Calmon MS, Sande Loureiro M, Freire de Melo F. Immunotherapy in glioblastoma treatment: Current state and future prospects. World J Clin Oncol 2023; 14(4): 138-159
URL: https://www.wjgnet.com/2218-4333/full/v14/i4/138.htm
DOI: https://dx.doi.org/10.5306/wjco.v14.i4.138